Stock market

Follow
Grifols executives in boardroom approving minority stake IPO for US Biopharma business, with surging stock charts on screens.
Image generated by AI

Grifols prepares stock listing for its US Biopharma business

Reported by AI Image generated by AI

Grifols' board has approved preparing a public offering (OPV) of a minority stake in its US Biopharma business to reduce debt and fund growth. The company will retain majority control and continue listing in Spain. Its ADRs surged up to 13% in after-hours trading.

The Ibovespa surged 3.24% on Monday (23), reaching 181,900 points, driven by Donald Trump's statements on US-Iran talks. Brent oil dropped 9.6% to $96.3, and the dollar fell to R$5.23.

Reported by AI

South Korean shares opened sharply lower on March 19 amid attacks on Middle East energy facilities during the US- and Israel-led war against Iran. The US Federal Reserve's decision to keep rates unchanged further dampened sentiment. The KOSPI fell 2.16% in the first 15 minutes.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline